Skip to content

Warming moxibustion clinical study on the treatment of postoperative upper extremity edema in breast cancer patients

Warming moxibustion clinical study on the treatment of postoperative upper extremity edema in breast cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONR-16009937
Enrollment
Unknown
Registered
2016-11-20
Start date
2016-12-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper limb lymphedema after radical mastectomy

Interventions

Warming moxibustion treatment group of BCRL patients:Warming moxibustion treatment
Patients with BCRL underwent pneumatic cycling - driven treatment:Pneumatic cycle driven therapy

Sponsors

The Third Affiliated Hospital of Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. In line with diagnostic criteria for upper extremity edema; 2. Patients aged 25 to 75 years; 3. Pathological diagnosis of breast cancer, radical mastectomy or radical surgery for postoperative breast cancer patients; 4. Conscious swelling or upper limb joint dysfunction in patients; 5. Voluntary test, signed informed consent, good compliance, to follow-up.

Exclusion criteria

Exclusion criteria: 1. Pregnant women, lactating women, vulnerable to allergies; 2. Tumor metastasis of lymph node metastasis; 3. With heart, liver and kidney or hematopoietic system and other serious primary disease; 4. Limb skin rash, papules, erythema, presence of herpes or trauma; 5. Have a history of chronic respiratory can not tolerate moxibustion odor.

Design outcomes

Primary

MeasureTime frame
The upper limb circumference numerical;Upper limb volume;Upper limb swelling score;Quality of Life Score (QLQ-C30);

Countries

China

Contacts

Public ContactPei Xiaohua

Beijing University of Chinese Medicine

pxh_127@163.com+86 13911683278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026